openTesamorelin 5mg

Tesamorelin 5mg

$65.00

For research purposes only. This product is not intended for use in humans or animals. Availability is strictly limited to laboratory research, analytical assay development, and investigative applications.

Add to wishlist
Share
Category

    Tesamorelin 5 mg Peptide Vials

    Tesamorelin is a synthetic growth‑hormone‑releasing hormone (GHRH) analogue. It was approved by the FDA under the brand name Egrifta® to reduce excess abdominal fat in adults with HIV‑associated lipodystrophy:contentReference[oaicite:3]{index=3}. The peptide stimulates pituitary GHRH receptors and increases insulin‑like growth factor‑1 (IGF‑1) and IGF‑binding protein‑3 levels:contentReference[oaicite:4]{index=4}.

    Attribute Details
    Active ingredient Tesamorelin acetate (5 mg per vial)
    Category GHRH analogue / growth hormone secretagogue
    Indication FDA‑approved for reducing visceral fat in HIV‑associated lipodystrophy; not a weight‑loss drug:contentReference[oaicite:5]{index=5}
    Mechanism of action Stimulates GHRH receptors to increase endogenous growth hormone secretion and IGF‑1 levels:contentReference[oaicite:6]{index=6}
    Administration Reconstitute with bacteriostatic water and administer subcutaneously; typical clinical dose is 2 mg daily:contentReference[oaicite:7]{index=7}:contentReference[oaicite:8]{index=8}
    Key considerations Contraindicated in pregnancy, active malignancy or pituitary disorders; possible side‑effects include injection‑site reactions and increased blood glucose:contentReference[oaicite:9]{index=9}:contentReference[oaicite:10]{index=10}.

    Disclaimer: For laboratory research only. Not for human or veterinary use.

    Reviews

    There are no reviews yet.

    Be the first to review “Tesamorelin 5mg”

    Your email address will not be published. Required fields are marked *

Related Products

BPC 157 10mg

BPC-157 10mg

 $65.00
.
GHK Cu

GHK-CU 50mg

 $50.00
.
mots c alpha

Mots-C 10mg

 $50.00
.
BAC Water

BAC Water

 $10.00
.